STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ACRX ACELRX PHARMACEUTICALS INCORPORATED StockScouter® Report
5
StockScouter® Score
ACELRX PHARMACEUTICALS INCORPORATED, a micro cap growth company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
- The enterprise value-to-sales ratio is lower than the average for comparably-sized companies in the StockScouter universe. Positive
Concerns
- Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
- The multi-period measure of relative price change and consistency is below average. Negative/Neutral
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be in favor, growth stocks will be in favor, and healthcare stocks will be in favor.
Expected Risk/Return
Core Model Grades
C
A
B
D